Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10965660 | Vaccine | 2014 | 6 Pages |
Abstract
We recommend that safety and efficacy studies with a liquid formulation of the vaccine are carried out in children under five, including those less than two years of age to determine if Ty21a is protective in these age groups and applicable as a public health tool for controlling typhoid fever in high prevalence areas of typhoid fever including Bangladesh.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Taufiqur R. Bhuiyan, Feroza K. Choudhury, Farhana Khanam, Amit Saha, Md. Abu Sayeed, Umme Salma, Anna Lundgren, David A. Sack, Ann-Mari Svennerholm, Firdausi Qadri,